AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomer™ RNA editing program to enter the clinic Company to host virtual ...

Data from INVOKE-2, evaluating TREM2 agonist candidate AL002 in patients with early Alzheimer’s disease (AD), on track for ...

After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Again as a reminder, today's conference is being recorded. At this time, I would like to turn the ...